The decision by biotechnology firm Turing Pharmaceuticals to raise the cost of Pyrimethamine (or Daraprim), a drug used to treat toxoplasmosis, from $13.50 to more than $750 per pill, has aroused shock and outrage. Toxoplasmosis is a parasitic disease to which people with weakened immune systems from of diseases such as AIDS, as well as certain cancer patients, as well …
MARY ELIZABETH WILLIAMS – “Martin Shkreli is the Donald Trump of drug development”: Why even a biotech exec agrees Turing’s pill price-gouging is “even skeevier than you think”
“Martin Shkreli is the Donald Trump of drug development,” my friend Frank tells me. “He’s a hedge fund manager who gives hedge fund managers a bad name.” Frank — a chief scientific officer at a biotech company (and whose name has been changed to protect his and his family’s privacy) — is talking to me Tuesday morning, en route to …